XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Taxes  
Schedule of components of income tax benefit (provision)

Year Ended December 31, 

    

2021

    

2020

    

2019

(In thousands)

Income tax benefit (provision):

Federal

$

18,513

$

16,615

$

13,869

State

7,082

5,802

2,170

Expiration of NOLs and R&D credit

(14,210)

(20,294)

(18,966)

11,385

2,123

(2,927)

Deferred tax valuation allowance

(11,158)

(956)

2,927

$

227

$

1,167

$

Schedule of reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate

    

2021

    

2020

    

2019

(In thousands)

Pre-tax loss

$

(70,738)

$

(60,947)

$

(50,878)

Loss at statutory rates

(14,855)

(12,799)

(10,684)

Research and development credits

(2,422)

(1,778)

(1,902)

State taxes

(7,082)

(5,802)

(2,170)

Other

(941)

(1,152)

(1,011)

Change in fair value remeasurement of contingent consideration

(295)

(886)

(272)

Expiration of NOLs and R&D credit

14,210

20,294

18,966

Change in valuation allowance

11,158

956

(2,927)

Income tax (benefit) provision

$

(227)

$

(1,167)

$

Schedule of principal components of the deferred tax assets and liabilities

    

December 31, 

    

December 31, 

2021

2020

(In thousands)

Gross deferred tax assets

Net operating loss carryforwards

$

183,711

$

174,369

Tax credit carryforwards

47,927

44,936

Deferred research and development expenses

59,753

63,215

Stock-based compensation

14,719

13,196

Fixed assets

1,287

1,303

Accrued expenses and other

370

325

307,767

297,344

Gross deferred tax liabilities

IPR&D intangibles

(6,840)

(7,802)

Total deferred tax assets and liabilities

300,927

289,542

Valuation allowance

(302,540)

(291,382)

Net deferred tax liability

$

(1,613)

$

(1,840)